Warnock James N, Nanduri Bindu, Pregonero Gamez Carol A, Tang Juliet, Koback Daniel, Muir William M, Burgess Shane C
Department of Agricultural and Biological Engineering, Mississippi State University, Mississippi State, MS 39762, USA.
Int J Inflam. 2011;2011:176412. doi: 10.4061/2011/176412. Epub 2011 Aug 18.
The study aimed to identify mechanosensitive pathways and gene networks that are stimulated by elevated cyclic pressure in aortic valve interstitial cells (VICs) and lead to detrimental tissue remodeling and/or pathogenesis. Porcine aortic valve leaflets were exposed to cyclic pressures of 80 or 120 mmHg, corresponding to diastolic transvalvular pressure in normal and hypertensive conditions, respectively. Linear, two-cycle amplification of total RNA, followed by microarray was performed for transcriptome analysis (with qRT-PCR validation). A combination of systems biology modeling and pathway analysis identified novel genes and molecular mechanisms underlying the biological response of VICs to elevated pressure. 56 gene transcripts related to inflammatory response mechanisms were differentially expressed. TNF-α, IL-1α, and IL-1β were key cytokines identified from the gene network model. Also of interest was the discovery that pentraxin 3 (PTX3) was significantly upregulated under elevated pressure conditions (41-fold change). In conclusion, a gene network model showing differentially expressed inflammatory genes and their interactions in VICs exposed to elevated pressure has been developed. This system overview has detected key molecules that could be targeted for pharmacotherapy of aortic stenosis in hypertensive patients.
该研究旨在确定主动脉瓣间质细胞(VICs)中由循环压力升高所刺激并导致有害组织重塑和/或发病机制的机械敏感通路和基因网络。将猪主动脉瓣叶分别暴露于80或120 mmHg的循环压力下,这分别对应于正常和高血压条件下的舒张期跨瓣压力。对总RNA进行线性双循环扩增,随后进行微阵列分析以进行转录组分析(并通过qRT-PCR验证)。系统生物学建模和通路分析相结合,确定了VICs对压力升高的生物学反应背后的新基因和分子机制。56个与炎症反应机制相关的基因转录本差异表达。肿瘤坏死因子-α(TNF-α)、白细胞介素-1α(IL-1α)和白细胞介素-1β(IL-1β)是从基因网络模型中确定的关键细胞因子。同样有趣的是发现五聚体蛋白3(PTX3)在压力升高条件下显著上调(变化41倍)。总之,已建立了一个基因网络模型,该模型显示了在压力升高的VICs中差异表达的炎症基因及其相互作用。这一系统概述检测到了可作为高血压患者主动脉瓣狭窄药物治疗靶点的关键分子。